Search for a report

GLOBAL PRECISION MEDICINE MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • GLOBAL PRECISION MEDICINE MARKET FORECAST 2021-2028

GLOBAL PRECISION MEDICINE MARKET FORECAST 2021-2028

The global precision medicine market is projected to register a CAGR of 9.86%, during the forecast years and is anticipated to generate revenue of $128929.1 million by 2028. The base year considered for the market study is 2020, and the forecast period is from 2021 to 2028. Precision medicine involves a detailed study of patient-specific information, in order to diagnose and characterize diseases. The medical model also holds immense potential to restructure the healthcare industry.

GLOBAL PRECISION MEDICINE MARKET FORECAST 2021-2028

Global Precision Medicine Market by Application (Oncology, Infectious Diseases, Neurology/physiatry, Cardiovascular, Lifestyle and Endocrinology, Gastroenterology, Other Applications) Market by Component (Applied Science (Genomics, Pharmacogenomics, Other Applied Sciences), Precision Therapeutics, Precision Diagnostics, Digital Health and Information Technology) and by Geography

Request free sample

The global precision medicine market is projected to register a CAGR of 9.86%, during the forecast years and is anticipated to generate revenue of $128929.1 million by 2028. The base year considered for the market study is 2020, and the forecast period is from 2021 to 2028.

Precision medicine involves a detailed study of patient-specific information, in order to diagnose and characterize diseases. The medical model also holds immense potential to restructure the healthcare industry.
precision-medicine-market

To learn more about this report, request a free sample copy

Key factors propelling the global precision medicine market growth:

  • Use of digital collaboration in exchanging useful information for developing precision medicine
    • The data generated from clinical research and gene sequencing forums play a crucial role in understanding the drug targets for personalized medicine.
    • Over recent years, several online collaborations have provided information that continues to propel the global precision medicine market growth.
  • Identification and characterization of essential genes in the human genome
  • Investments by government and private players to find an effective treatment for different types of cancers
  • Prevalence of precision medicine to tackle chronic conditions
  • Demand for preventive care

Major growth restraining factors:

  • Security risk associated with data sharing
    • The key privacy challenges faced by precision medicine initiatives across the world include the question of what could be done with the data collected.
  • Difficulty in acquiring pharmacotherapy approval for a new drug
  • Uncertainty regarding reimbursement and regulatory policies

The report scope of the global precision medicine market includes the segmentation analysis of application and component. One of these segments is further classified to provide a detailed analysis of the studied market.

Market by Application:

  • Oncology
    • The oncology segment dominated the application category in 2020.
    • Research and development related to precision medicine significantly focus on precision oncology.
    • Cancer precision medicine aims to provide the most precise and effective treatment to individual cancer patients.
  • Lifestyle and Endocrinology
    • Lifestyle and endocrinology is the fastest-growing application.
    • Precision medicine to treat lifestyle diseases and endocrine disorders such as blood pressure, cholesterol, and diabetes, among others, is still in the nascent stage.
    • Ongoing research activities and increasing knowledge of the researchers on molecular causes of diabetes facilitate tool upgradation. As a result, this factor enables the identification of patients at very early stages.
  • Infectious Diseases
  • Neurology/Physiatry
  • Cardiovascular
  • Gastroenterology
  • Other Applications

Geographically, the global precision medicine market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America is set to dominate the global market over the forecast years.
    • Several well-known diagnostics manufacturers across the region concentrate on increasing their portfolio in NGS-based diagnostics.
    • They also cooperate with pharmaceutical giants and service providers to co-market molecular diagnostics approaches with corresponding precision medicine solutions, thereby driving the market growth.
  • Europe: Belgium, the United Kingdom, Germany, Italy, France, Russia, Poland, and Rest of Europe
  • Asia-Pacific: India, Australia & New Zealand, South Korea, China, Japan, Indonesia, Thailand, Vietnam, and Rest of Asia Pacific
    • Asia-Pacific is evaluated to be the leading region during the forecast period.
    • Various governmental initiatives for precision medicine are projected to boost the market growth in Europe.
    • The establishment of efficient data collection libraries across the European states effectively monitors utilization across the region.
    • Germany is one of the emerging European countries in precision medicine. In this regard, personalized medicine enjoys high priority in the Health Research Framework Program of the German Federal Government.
  • Rest of World: Latin America, the Middle East & Africa

Major market players within the global precision medicine market:

  • Abbott laboratories
  • Astra Zeneca PLC
  • Bio-Rad Laboratories Inc
  • Eli Lilly & Company
  • Hoffmann-La Roche
  • Others

Key strategies adopted by some of these companies:

In September 2020, AstraZeneca acquired Dogma Therapeutics’ clinical oral PCSK9 inhibitor program. With the program’s initiation, the company is anticipated to move forward into clinical development for dyslipidemia and familial hypercholesterolemia.

Key findings of the global precision medicine market:

  • Development in gene therapy is a crucial factor propelling the market growth.
  • Collaboration among corporations is set to offer lucrative opportunities for players across the value chain.
  • Developing countries like China, India, and South Africa comprise high disease risk populations, thus expanding the emerging precision medicine market.

 

Frequently Asked Questions (FAQs):

  • What is the concept of precision medicine?

A: The concept of precision medicine involves comprehending the genetic makeup and alteration at a population-level, and at an individual level, to customize a drug that targets the particular gene type.

  • Why did the use of precision medicine surge during the COVID-19 pandemic?

A: Precision medicine approaches are useful in understanding variations in individuals’ responses and susceptibility to COVID-19. For instance, as per a recent study, severe COVID-19 infections are linked with gene variants on chromosome 9 (9q34.2), and chromosome 3 (3p21.31), ApoE e4 genotype, as well as loss-of-function variants on X-chromosomal TLR7. Therefore, the use of precision medicine surged during the COVID-19 pandemic.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • DEVELOPMENT OF PRECISION MEDICINE
    • KEY DRIVERS
      • USAGE OF DIGITAL COLLABORATION IN EXCHANGING USEFUL INFORMATION FOR DEVELOPING PRECISION MEDICINE
      • IDENTIFICATION AND CHARACTERIZATION OF ESSENTIAL GENES IN THE HUMAN GENOME
      • PREVALENCE OF PRECISION MEDICINE TO TACKLE CHRONIC CONDITION
      • DEMAND FOR PREVENTIVE CARE
    • KEY RESTRAINTS
      • SECURITY RISKS ASSOCIATED WITH DATA SHARING
      • DIFFICULTY IN ACQUIRING PHARMACOTHERAPY APPROVAL FOR A NEW DRUG
      • UNCERTAINTY ASSOCIATED WITH REIMBURSEMENT AND REGULATORY POLICIES
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON PRECISION MEDICINE MARKET
    • KEY INVESTMENT INSIGHTS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRIES
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • TECHNOLOGIES RELATED TO PRECISION MEDICINE
    • SUPPLY CHAIN ANALYSIS
    • REGULATORY FRAMEWORK
  2. MARKET BY APPLICATION
    • ONCOLOGY
    • INFECTIOUS DISEASES
    • NEUROLOGY/PHYSIATRY
    • CARDIOVASCULAR
    • LIFESTYLE AND ENDOCRINOLOGY
    • GASTROENTEROLOGY
    • OTHER APPLICATIONS
  3. MARKET BY COMPONENT
    • APPLIED SCIENCE
      • GENOMICS
        • PCR
        • PM NGS
        • GENOME EDITING
        • OTHER GENOMICS TECHNOLOGIES
      • PHARMACOGENOMICS
      • OTHER APPLIED SCIENCES
    • PRECISION THERAPEUTICS
      • CLINICAL TRIALS
      • CELL THERAPY
      • DRUG DISCOVERY AND RESEARCH
      • GENE THERAPY
    • PRECISION DIAGNOSTICS
      • MOLECULAR DIAGNOSTICS
        • NON-INVASIVE PRENATAL TESTING (NIPT)
        • COMPANION DIAGNOSTICS
        • LIQUID BIOPSY
        • OTHER MOLECULAR DIAGNOSTICS
      • MEDICAL IMAGING
        • IMAGING ANALYTICS
        • IMAGING COMPUTER-AIDED DETECTION (CADX)
    •  DIGITAL HEALTH AND INFORMATION TECHNOLOGY
      • CLINICAL DECISION SUPPORT SYSTEMS (CDSS)
      • BIG DATA ANALYTICS
      • IT INFRASTRUCTURE
      • GENOMICS INFORMATICS
      • IN-SILICO INFORMATICS
      • MOBILE HEALTH
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    •  EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • GERMANY
        • FRANCE
        • UNITED KINGDOM
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    •  ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • AUSTRALIA & NEW ZEALAND
        • INDIA
        • SOUTH KOREA
        • THAILAND
        • MALAYSIA
        • SINGAPORE
        • REST OF ASIA-PACIFIC
    •  REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
      • BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
    • COMPANY PROFILES
      • ABBOTT LABORATORIES
      • ASTRA ZENECA PLC
      • BIOCRATES LIFE SCIENCES AG
      • BIO-RAD LABORATORIES INC
      • DANAHER CORPORATION
      • EAGLE GENOMICS LTD
      • ELI LILLY & COMPANY
      • HOFFMANN-LA ROCHE
      • INTOMICS
      • LABORATORY CORPORATION OF AMERICA HOLDINGS
      • NANOSTRING TECHNOLOGIES
      • NOVARTIS AG
      • PFIZER INC
      • QIAGEN NV
      • QUEST DIAGNOSTICS INCORPORATED

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – PRECISION MEDICINE

TABLE 2: GLOBAL PRECISION MEDICINE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: GLOBAL PRECISION MEDICINE MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: GLOBAL ONCOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: GLOBAL ONCOLOGY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL INFECTIOUS DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: GLOBAL INFECTIOUS DISEASES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL NEUROLOGY/PHYSIATRY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: GLOBAL NEUROLOGY/PHYSIATRY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL CARDIOVASCULAR MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: GLOBAL CARDIOVASCULAR MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: GLOBAL LIFESTYLE AND ENDOCRINOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: GLOBAL LIFESTYLE AND ENDOCRINOLOGY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: GLOBAL GASTROENTEROLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: GLOBAL GASTROENTEROLOGY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 18: GLOBAL PRECISION MEDICINE MARKET, BY COMPONENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: GLOBAL PRECISION MEDICINE MARKET, BY COMPONENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 20: GLOBAL APPLIED SCIENCE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 21: GLOBAL APPLIED SCIENCE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 22: GLOBAL APPLIED SCIENCE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 23: GLOBAL APPLIED SCIENCE MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 24: GLOBAL GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 25: GLOBAL GENOMICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 26: GLOBAL GENOMICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 27: GLOBAL GENOMICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 28: GLOBAL PCR GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 29: GLOBAL PCR GENOMICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 30: GLOBAL PM NGS GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 31: GLOBAL PM NGS GENOMICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 32: GLOBAL GENOME EDITING GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 33: GLOBAL GENOME EDITING GENOMICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 34: GLOBAL OTHER GENOMICS TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 35: GLOBAL OTHER GENOMICS TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 36: GLOBAL PHARMACOGENOMICS APPLIED SCIENCE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 37: GLOBAL PHARMACOGENOMICS APPLIED SCIENCE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 38: GLOBAL OTHER APPLIED SCIENCES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 39: GLOBAL OTHER APPLIED SCIENCES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 40: GLOBAL PRECISION THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 41: GLOBAL PRECISION THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 42: GLOBAL PRECISION THERAPEUTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 43: GLOBAL PRECISION THERAPEUTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 44: GLOBAL CLINICAL TRIALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 45: GLOBAL CLINICAL TRIALS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 46: GLOBAL CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 47: GLOBAL CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 48: GLOBAL DRUG DISCOVERY AND RESEARCH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 49: GLOBAL DRUG DISCOVERY AND RESEARCH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 50: GLOBAL GENE THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 51: GLOBAL GENE THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 52: GLOBAL PRECISION DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 53: GLOBAL PRECISION DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 54: GLOBAL PRECISION DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 55: GLOBAL PRECISION DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 56: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 57: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 58: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 59: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 60: GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 61: GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 62: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 63: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 64: GLOBAL LIQUID BIOPSY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 65: GLOBAL LIQUID BIOPSY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 66: GLOBAL OTHER MOLECULAR DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 67: GLOBAL OTHER MOLECULAR DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 68: GLOBAL MEDICAL IMAGING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 69: GLOBAL MEDICAL IMAGING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 70: GLOBAL MEDICAL IMAGING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 71: GLOBAL MEDICAL IMAGING MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 72: GLOBAL IMAGING ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 73: GLOBAL IMAGING ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 74: GLOBAL IMAGING COMPUTER-AIDED DETECTION (CADX) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 75: GLOBAL IMAGING COMPUTER-AIDED DETECTION (CADX) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 76: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 77: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 78: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 79: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 80: GLOBAL CLINICAL DECISION SUPPORT SYSTEMS (CDSS) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 81: GLOBAL CLINICAL DECISION SUPPORT SYSTEMS (CDSS) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 82: GLOBAL BIG DATA ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 83: GLOBAL BIG DATA ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 84: GLOBAL IT INFRASTRUCTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 85: GLOBAL IT INFRASTRUCTURE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 86: GLOBAL GENOMICS INFORMATICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 87: GLOBAL GENOMICS INFORMATICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 88: GLOBAL IN-SILICO INFORMATICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 89: GLOBAL IN-SILICO INFORMATICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 90: GLOBAL MOBILE HEALTH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 91: GLOBAL MOBILE HEALTH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 92: GLOBAL PRECISION MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 93: GLOBAL PRECISION MEDICINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 94: NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 95: NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 96: LEADING PLAYERS OPERATING IN NORTH AMERICA PRECISION MEDICINE MARKET

TABLE 97: EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 98: EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 99: LEADING PLAYERS OPERATING IN EUROPE PRECISION MEDICINE MARKET

TABLE 100: ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 101: ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 102: LEADING PLAYERS OPERATING IN ASIA-PACIFIC PRECISION MEDICINE MARKET

TABLE 103: REST OF WORLD PRECISION MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 104: REST OF WORLD PRECISION MEDICINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 105: LEADING PLAYERS OPERATING IN REST OF WORLD PRECISION MEDICINE MARKET

TABLE 106: LIST OF MERGERS & ACQUISITIONS

TABLE 107: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS

TABLE 108: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 109: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: CHRONIC CONDITIONS IN PATIENTS HOSPITALIZED WITH COVID-19 IN THE UNITED STATES

FIGURE 2: KEY INVESTMENT INSIGHTS

FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: GLOBAL PRECISION MEDICINE MARKET, BY APPLICATION, IN 2020

FIGURE 7: GLOBAL PRECISION MEDICINE MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL PRECISION MEDICINE MARKET, BY INFECTIOUS DISEASES, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL PRECISION MEDICINE MARKET, BY NEUROLOGY/PHYSIATRY, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL PRECISION MEDICINE MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL PRECISION MEDICINE MARKET, BY LIFESTYLE AND ENDOCRINOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL PRECISION MEDICINE MARKET, BY GASTROENTEROLOGY, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL PRECISION MEDICINE MARKET, BY OTHER APPLICATIONS,2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL PRECISION MEDICINE MARKET, BY COMPONENT, IN 2020

FIGURE 15: GLOBAL PRECISION MEDICINE MARKET, BY APPLIED SCIENCE, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL APPLIED SCIENCE MARKET, BY GENOMICS, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL GENOMICS MARKET, BY PCR, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL GENOMICS MARKET, BY PM NGS, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL GENOMICS MARKET, BY GENOME EDITING, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL GENOMICS MARKET, BY OTHER GENOMICS TECHNOLOGIES, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL APPLIED SCIENCE MARKET, BY PHARMACOGENOMICS, 2021-2028 (IN $ MILLION)

FIGURE 22: BIOMARKER’S ROLE IN PHARMACOGENOMICS

FIGURE 23: GLOBAL APPLIED SCIENCES MARKET, BY OTHER APPLIED SCIENCES, 2021-2028 (IN $ MILLION)

FIGURE 24: GLOBAL PRECISION MEDICINE MARKET, BY PRECISION THERAPEUTICS, 2021-2028 (IN $ MILLION)

FIGURE 25: GLOBAL PRECISION THERAPEUTICS MARKET, BY CLINICAL TRIALS, 2021-2028 (IN $ MILLION)

FIGURE 26: GLOBAL PRECISION THERAPEUTICS MARKET, BY CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 27: GLOBAL PRECISION THERAPEUTICS MARKET, BY DRUG DISCOVERY AND RESEARCH, 2021-2028 (IN $ MILLION)

FIGURE 28: GLOBAL PRECISION THERAPEUTICS MARKET, BY GENE THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 29: GLOBAL PRECISION MEDICINE MARKET, BY PRECISION DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 30: GLOBAL PRECISION DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 31: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY NON-INVASIVE PRENATAL TESTING (NIPT), 2021-2028 (IN $ MILLION)

FIGURE 32: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 33: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY LIQUID BIOPSY, 2021-2028 (IN $ MILLION)

FIGURE 34: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY OTHER MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 35: GLOBAL PRECISION DIAGNOSTICS MARKET, BY MEDICAL IMAGING, 2021-2028 (IN $ MILLION)

FIGURE 36: GLOBAL MEDICAL IMAGING MARKET, BY IMAGING ANALYTICS, 2021-2028 (IN $ MILLION)

FIGURE 37: GLOBAL MEDICAL IMAGING MARKET, BY IMAGING COMPUTER-AIDED DETECTION (CADX), 2021-2028 (IN $ MILLION)

FIGURE 38: GLOBAL PRECISION MEDICINE MARKET, BY DIGITAL HEALTH AND INFORMATION TECHNOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 39: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY CLINICAL DECISION SUPPORT SYSTEMS (CDSS), 2021-2028 (IN $ MILLION)

FIGURE 40: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY BIG DATA ANALYTICS, 2021-2028 (IN $ MILLION)

FIGURE 41: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IT INFRASTRUCTURE, 2021-2028 (IN $ MILLION)

FIGURE 42: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY GENOMICS INFORMATICS, 2021-2028 (IN $ MILLION)

FIGURE 43: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IN-SILICO INFORMATICS, 2021-2028 (IN $ MILLION)

FIGURE 44: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY MOBILE HEALTH, 2021-2028 (IN $ MILLION)

FIGURE 45: NORTH AMERICA PRECISION MEDICINE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 46: UNITED STATES PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 47: CANADA PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 48: EUROPE PRECISION MEDICINE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 49: GERMANY PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 50: FRANCE PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 51: UNITED KINGDOM PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 52: ITALY PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 53: RUSSIA PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 54: BELGIUM PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 55: POLAND PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 56: REST OF EUROPE PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 57: ASIA-PACIFIC PRECISION MEDICINE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 58: CHINA PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 59: JAPAN PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 60: AUSTRALIA & NEW ZEALAND PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 61: INDIA PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 62: SOUTH KOREA PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 63: THAILAND PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 64: MALAYSIA PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 65: SINGAPORE PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 66: REST OF ASIA-PACIFIC PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 67: REST OF WORLD PRECISION MEDICINE MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 68: LATIN AMERICA PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 69: MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

  1. MARKET BY APPLICATION
    • ONCOLOGY
    • INFECTIOUS DISEASES
    • NEUROLOGY/PHYSIATRY
    • CARDIOVASCULAR
    • LIFESTYLE AND ENDOCRINOLOGY
    • GASTROENTEROLOGY
    • OTHER APPLICATIONS
  2. MARKET BY COMPONENT
    • APPLIED SCIENCE
      • GENOMICS
        • PCR
        • PM NGS
        • GENOME EDITING
        • OTHER GENOMICS TECHNOLOGIES
      • PHARMACOGENOMICS
      • OTHER APPLIED SCIENCES
    • PRECISION THERAPEUTICS
      • CLINICAL TRIALS
      • CELL THERAPY
      • DRUG DISCOVERY AND RESEARCH
      • GENE THERAPY
    • PRECISION DIAGNOSTICS
      • MOLECULAR DIAGNOSTICS
        • NON-INVASIVE PRENATAL TESTING (NIPT)
        • COMPANION DIAGNOSTICS
        • LIQUID BIOPSY
        • OTHER MOLECULAR DIAGNOSTICS
      • MEDICAL IMAGING
        • IMAGING ANALYTICS
        • IMAGING COMPUTER-AIDED DETECTION (CADX)
    •  DIGITAL HEALTH AND INFORMATION TECHNOLOGY
      • CLINICAL DECISION SUPPORT SYSTEMS (CDSS)
      • BIG DATA ANALYTICS
      • IT INFRASTRUCTURE
      • GENOMICS INFORMATICS
      • IN-SILICO INFORMATICS
      • MOBILE HEALTH
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    •  EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • GERMANY
        • FRANCE
        • UNITED KINGDOM
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    •  ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • AUSTRALIA & NEW ZEALAND
        • INDIA
        • SOUTH KOREA
        • THAILAND
        • MALAYSIA
        • SINGAPORE
        • REST OF ASIA-PACIFIC
    •  REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

 

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Choose License Type

    Buy Now